Seven Mile Advisory’s Eli Lilly LLY Stock Holding History

Seven Mile Advisory’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.16M	Sell	1,265 -541	-30%	-$548K	0.84%	20
2025 Q4	$1.94M	Sell	1,806 -13	-0.7%	-$12.4K	0.33%	48
2025 Q3	$1.39M	Buy	1,819 +416	+30%	+$310K	0.22%	66
2025 Q2	$1.09M	Sell	1,403 -149	-10%	-$116K	0.66%	29
2025 Q1	$1.28M	Buy	1,552 +202	+15%	+$168K	0.86%	22
2024 Q4	$1.04M	Buy	1,350 +51	+4%	+$42.2K	0.66%	27
2024 Q3	$1.15M	Buy	1,299 +163	+14%	+$147K	0.76%	24
2024 Q2	$1.03M	Buy	1,136 +44	+4%	+$35.2K	0.76%	22
2024 Q1	$850K	Buy	1,092 +32	+3%	+$22.8K	0.64%	28
2023 Q4	$618K	Buy	1,060 +57	+6%	+$33.3K	0.54%	39
2023 Q3	$539K	Buy	1,003 +34	+4%	+$17.5K	0.57%	37
2023 Q2	$454K	Buy	+969	New	+$406K	0.53%	44

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Seven Mile Advisory's LLY Position: Q1 2026 in Review

Seven Mile Advisory reduced its Eli Lilly (LLY) stake by 30% in Q1 2026, selling an estimated $548K and leaving 1,265 shares worth $1.16M. The position accounts for 0.84% of the portfolio, ranked #20.

Seven Mile Advisory first reported a position in LLY in Q2 2023 and has held it in 12 quarters since. The position peaked at $1.94M in Q4 2025. 4,354 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

Seven Mile Advisory held 1,265 shares of Eli Lilly worth $1.16M as of Q1 2026.
Seven Mile Advisory sold 541 Eli Lilly shares in Q1 2026, an estimated $548K.
Eli Lilly made up 0.84% of Seven Mile Advisory's portfolio in Q1 2026, its #20 holding.
Seven Mile Advisory first reported a position in Eli Lilly in Q2 2023 and has held it in 12 quarters since.
Seven Mile Advisory's Eli Lilly position peaked at $1.94M in Q4 2025.
4,354 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Seven Mile Advisory's 13F filing for Q1 2026, filed 14 Apr 2026.